Nektar Therapeutics
(NKTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -78,838 | -46,201 | -162,013 | -114,354 | -97,811 |
| Depreciation Amortization | 6,519 | 3,264 | 14,275 | 10,882 | 7,281 |
| Accounts receivable | -818 | 374 | 3,576 | 1,248 | -236 |
| Accounts payable and accrued liabilities | -1,818 | -6,126 | 6,199 | 697 | 2,631 |
| Other Working Capital | -8,357 | -24,105 | 90,585 | -6,083 | 6,515 |
| Other Operating Activity | 11,937 | 10,504 | 8,851 | 15,452 | 9,172 |
| Operating Cash Flow | $-71,375 | $-62,290 | $-38,527 | $-92,158 | $-72,448 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -268,068 | 274,011 | N/A |
| PPE Investments | -5,192 | -4,524 | -4,091 | -1,382 | -794 |
| Purchase Of Investment | -166,496 | -110,661 | N/A | -140,569 | -109,400 |
| Sale Of Investment | 118,777 | 56,972 | 322,068 | N/A | 200,477 |
| Investing Cash Flow | $-52,911 | $-58,213 | $49,909 | $132,060 | $90,283 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,650 | -825 | -2,992 | -2,201 | -1,466 |
| Common Stock Issued | 124,562 | 121,693 | 8,208 | 5,253 | 2,621 |
| Other Financing Activity | -7,000 | -7,000 | -3,000 | -3,000 | -3,000 |
| Financing Cash Flow | $115,912 | $113,868 | $2,216 | $52 | $-1,845 |
| Exchange Rate Effect | 6 | 11 | 32 | 20 | 5 |
| Beginning Cash Position | 39,067 | 39,067 | 25,437 | 25,437 | 25,437 |
| End Cash Position | 30,699 | 32,443 | 39,067 | 65,411 | 41,432 |
| Net Cash Flow | $-8,368 | $-6,624 | $13,630 | $39,974 | $15,995 |
| Free Cash Flow | |||||
| Operating Cash Flow | -71,375 | -62,290 | -38,527 | -92,158 | -72,448 |
| Capital Expenditure | -5,192 | -4,524 | -4,091 | -1,382 | -794 |
| Free Cash Flow | -76,567 | -66,814 | -42,618 | -93,540 | -73,242 |